A paper in Contraception that purported to show serious flaws in an earlier study of abortion laws and maternal health has been retracted, after the authors of the original study found what were apparently significant flaws in the study doing the debunking.
That’s the short version of this story. The longer version involves years of back-and-forth, accusations of conflict of interest and poor research practice, and lawyers for at least two parties. Be warned: We have an unusual amount of information to quote from here that’s worth following.
As the editor of Contraception, Carolyn Westhoff, put it:
A researcher, formerly of Bath Spa University in the UK, who studies how computer games are designed, has retracted a paper and corrected three others after she said she became aware that they all contained plagiarism.
focuses on praxis in design for persuasive technology, multimedia installations, and affective knowledge, including the application of games for social issues such as higher education, homelessness, juvenile offenders, children in care, and healthcare.
Last December, Tianyi Wang and her colleagues published a very interesting paper in Cell Metabolism on the potential link between a gene called JAK/STAT3 and breast cancer. It turns out that breast cancers become resistant to chemotherapy via a pathway that involves JAK/STAT3, and blocking this pathway can re-sensitize the tumor to chemotherapy.
The wheels of scientific publishing turn slowly … but they do (sometimes) turn.
In January, we reported on the case of a paper on global warming marred by several problems, including allegations of plagiarism and “false claims” by the authors — which readers had raised as early as 2014, with no result. (Find a discussion of those allegations here.)
Six months ago, the media was ablaze with the findings of a new paper, showing that nearly six percent of cancer cases are caused, at least in part, by obesity and diabetes. But this week, the journal retracted that paper — and replaced it with a revised version.
The new paper doesn’t change the main findings much — the share of all cancers attributable to diabetes and obesity changed from 5.6% to 5.7%, which wouldn’t change any headlines about the original paper. But soon after the paper was published, a group of researchers noticed the authors’ mistake — which was significant enough to prompt the journal to retract the paper entirely, and swap it with a new one.
Decades ago, unbeknownst to each other, two chemists were independently working on a screening approach to identify new potential drugs. Both published papers about the technique around the same time. So now, when scientists write papers that cite the technique, who should get credit for discovering it?
Decades later, that question still hasn’t been answered — and the researchers continue to argue, this time over one’s decision not to cite the other’s work.
A researcher whose work on the use of nanomaterials has been heavily scrutinized on PubPeer — with one critic alleging a paper contained “obviously fabricated” images — has lost eight papers. [Editor’s note: See update below.]
The eight articles — seven from Biosensors and Bioelectronics and one from Analytica Chimica Acta, both published by Elsevier — all cite issues related to duplications, and conclude with some version of the following: